Blog

Check out the latest news and insights from DrugDev
Category: SCOPE

Where to find DrugDev at SCOPE 2016

Don’t miss these SCOPE sessions featuring DrugDev experts: Monday, February 22 Pre-SCOPE Kickoff Happy Hour with DrugDev, Praxis, CISCRP and CHI Join us for casual networking, drinks and fun door…

Read Full Post
Category: SCOPE

Can We Shift Investigators from “1 and done” to Repeat Performers

The challenge of the ‘1 and done’ investigators (i.e., investigators who do not return to perform a second clinical trial) is one that has been talked about for years. Why…

Read Full Post
Category: SCOPE, Uncategorized

Start SCOPE on the Right Foot

Join DrugDev, Praxis, CHI and CISCRP for our annual pre-SCOPE happy hour. Plenty of drinks and apps will be served. Please RSVP by February 17 to join in on the…

Read Full Post
Category: SCOPE

SCOPE 2016 – How One (Golden) Number Can Transform Clinical Trials

For years pharmaceutical companies and CROs have struggled to collect, clean and collate site data from disparate sources so they can make better decisions about site feasibility and selection. With…

Read Full Post
Category: SCOPE

SCOPE 2016 – Faces in the Crowd: Why We Do What We Do

The concept of the “Abstract Patient” has become too common in our industry, especially at conferences where we gather to discuss ideas and debate the best ways to support them….

Read Full Post
Category: Innovation, SCOPE

SCOPE 2016 – Sneak Preview: Speed Site Activation Using Collaborative Technology for Contracting and Essential Site Doc

Join DrugDev President & CEO Ibraheem (Ibs) Mahmood and Melissa (Liss) Easy,  Founder of DrugDev and President of Site Identification and Activation for lunch Wednesday, February 24 at SCOPE for…

Read Full Post
Category: Innovation, SCOPE

Why Technology Fails

Join Hugo Stephenson MD, Chairman of DrugDev, founder of the DrugDev Innovation lab and Primary Investigator on Tuesday, February 23, 4pm at SCOPE as he facilitates a discussion on Why…

Read Full Post
Category: Interview, video

Dr Jeffrey Rosen, Family Medicine, Investigator View Interview

Dr Jeffrey Rosen, Family Physician, shares his views on clinical trials; what the benefits are for both investigators and patients; the challenges he faces and how the industry could improve…

Read Full Post
Category: Innovation, Payments

How Can You Improve Site Payments?

With over $1.5 billion paid to sites worldwide, DrugDev has developed proven best practices which we are happy to share with you. Schedule a free consultation and we’ll make specific and…

Read Full Post
Category: Future

Changing Pharma One Clinical Trial at a Time

Our President and CEO Ibs Mahmood talked with Dan Sfera, “The Clinical Trials Guru,” about where the clinical industry is headed in 2016 and beyond. It costs 10 times as…

Read Full Post